Zusammenfassung
Organspende ist eine Gemeinschaftsaufgabe der Krankenhäuser und der Transplantationszentren. Die Deutsche Stiftung Organtransplantation (DSO) wurde mit der bundesweiten Koordinierung des Organspendeprozesses betraut (Koordinierungsstelle). Aufgabe der DSO ist u.a. durch Entnahme und Bereitstellung geeigneter Spenderorgane die gesundheitlichen Risiken der Organempfänger so gering wie möglich zu halten („Empfängerschutz“) und die dazu notwendigen Untersuchungen sicher zu stellen. Diese umfassen Organfunktionsprüfungen, Immunologie, Virologie, Bakteriologie, Blutgruppenbestimmung und Pathologie. Unabdingbar sind außerdem eine sorgfältige Anamneseerhebung und die daraus folgende Abklärung aller Anhaltspunkte für ein erhöhtes Übertragungsrisiko durch Vorerkrankungen des Spenders.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Angelis M, Cooper JT, Freemann RB (2003) Impact of donor infections on outcome of orthotopic liver transplantation. Liver Transplantation 9(5):451–462
Buell JF, Trofe J, Sethuraman G, Hanaway MJ, Beebe TM, Gross TG, Alloway R, First MR, Woodle ES (2003) Donors with central nervous system malignancies: are they truly safe? Transplantation 76(2):340–343
Center for Disease Control (CDC) (1994) HIV counselling, testing and referral Standards and guidelines. Atlanta, GA: US Department of Health and Human Services, Public Health Service, CDC
CDC (2002) Guidance for Industry: Recommendations for Deferral of Donors and Quarantine and Retrieval of Blood and Blood Products in Recent Recipients of Smallpox Vaccine (Vaccinia Virus) and Certain Contacts of Smallpox Vaccine Recipients — 12/30/2002 — (Corrected 2/4/2003) http://www.fda.gov/cber/gdlns/smpox-defquar.htm
CDC (2002) Guidance for Industry: Revised Preventive Measures to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease (CJD) and Variant Creutzfeldt-Jakob Disease (vCJD) by Blood and Blood Products — 1/9/2002 http://www.fda.gov/cber/gdlns/cjdvcjd.htm
CDC (2003) Draft Guidance for Industry: Revised Recommendations for Donor and Product Management Based on Screening Tests for Syphilis — 6/25/2003 http://www.fda.gov/cber/gdlnslsyphilis.htm
CDC (2003) Guidance for Industry: Revised Recommendations for the Assessment of Donor Suitability and Blood and Blood Product Safety in Cases of Known or Suspected West Nile Virus Infection — 5/1/2003 http://www.fda.gov/cber/gdlns/wnvguid.htm
CDC (2003) Guidelines for Laboratory Testing and Result Reporting of Antibody to Hepatitis C Virus. MMWR, 52, No. RR-3: http://www.cdc.gov/mmwr/preview/mmwrht-mVrr5203al.htm
Committee on the Microbiological Safety of Blood and Tissues for Transplantation (MSBT), Department of Health (2000) Guidance on the Microbiological Safety of Blood and Tissues for Transplantation, London www.doh.gov.uk/msbt
Delmonico FL, Snydman DR (1998) Organ donor screening for infectious diseases: review of practice and implications for transplantation. Transplantation 65(5):603–610
Detry O, Honore P, Hans MF, Delbouille MH, Jacquet N, Meurisse M (2000) Organ donors with primary central nervous System tumor. Transplantation 70(l):249–252
Emery VC (2001) Investigation of CMV disease in immunocompromised patients. J Clin Pathol 54:84–88
Eurotransplant Manual (2003) http://www.eurotransplant.nl; http://www.eurotransplant.nl/Members/files/forms/donorinformationform.pdf
Feng S, Buell JF, Cherikh WS, Deng MC, Hanto DW, Kauffman HM, Leichtman AB, Lorber MI, Maters RG, McBride MA, Metzger RA, Nolte FS, O’Connor KJ, Roth D, Terrault NA, Henry ML (2002) Organ donors with positive viral serology or malignancy: risk of disease transmission by transplantation. Transplantation 74(12):1657–1663
Fischer L, Sterneck M, Claus M, Costard-Jackle A, Fleischer B, Herbst H, Rogiers X, Broelsch CE (1999) Transmission of malaria tertiana by multiorgan donation. Clin Transplant 13(6):491–495
Freeman RB, Giatras I, Falagas ME, Supran S, O’Connor K, Bradley J, Snydman DR, Delmonico FL (1999) Outcome of transplantation of organs procured from bacteremic donors. Transplantation 68(8):1107–1111
Guide on safety and quality assurance for organs, tissues and cells (2002) Council of Europe
Ironside JW, Head MW (2003) Variant Creutzfeldt-Jakob disease and its transmission by blood. J Thromb Haemost 1(7):1479–1486
Iwamoto M, Jernigan DB, Guasch A, Trepka MJ, Blackmore CG, Hellinger WC, Pham SM, Zaki S, Lanciotti RS, Lance-Parker SE, Diaz Granados CA, Winquist AG, Perlino CA, Wiersma S, Hillyer KL, Goodman JL, Marfin AA, Chamberland ME, Petersen LR (2003) Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med 348(22):2196–2203
Kauffman HM, McBride MA, Cherikh WS, Spain PC, Delmonico FL (2002) Transplant tumor registry: donors with central nervous System tumorsl. Transplantation 73(4):579–582
Kauffman HM, McBride MA, Cherikh WS, Spain PC, Marks WH, Roza AM (2002) Transplant tumor registry: donor related malignancies. Transplantation 74(3):358–362
Kretzschmar Hans, Prof. Dr., Direktor des Instituts für Neuropathologie, Ludwig-Maximilians-Universität München (2003) Persönliche Mitteilung
Lopez-Navidad A, Caballero F (2003) Extended criteria for organ acceptance. Strategies for achieving organ safety and for increasing organ pool. Clin Transplant 17(4):308–324
Lumbreras C, Sanz F, Gonzalez A, Perez G, Ramos MJ, Aguado JM, Lizasoain M, Andres A, Moreno E, Gomez MA, Noriega AR (2001) Clinical significance of donor-unrecognized bacteremia in the outcome of solidorgan transplant recipients. Clin Infect Dis 33(5):722–726
Mauer D, Gabel D, Eisenreich S, Smit H (2003) Organspende in Deutschland: Aktuelle Situation und Zukunftperspektive. Intensivmed 40:538–548
Saab S, Chang AJ, Comulada S, Geevarghese SK, Anselmo RD, Durazo F, Han S, Farmer DG, Yersiz H, Goldstein LI, Ghobrial RM, Busuttil RW (2003) Outcomes of hepatitis C-and hepatitis B core antibody-positive grafts in orthotopic liver transplantation. Liver Transpl 9(10):1053–1061
Select Committee of Experts on the Organisational Aspects of Cooperation in Organ Transplantation. Council of Europe (1996) State of the art report on serological screening methods for the most relevant microbiological diseases of organ and tissue donors. Transplant Newsletter 1:16–18
Select Committee of Experts on the Organisational Aspects of Cooperation in Organ Transplantation. Council of Europe (2001) International Consensus Document. Standardization of Organ Donor Screening to Prevent Transmission of Neoplastic Diseases. Transplant Newsletter 6:45–51
The European Best Practice Guidelines Expert Group on Renal Transplantation (2000) Evaluation and selection of donors. Nephrol Dial Transplant 15(Suppl 7):39–51
Vollmer RJ, Langerhans G (eds) (1997) Das neue Transplantationsgesetz (TPG). AOK-Verlag, Remagen
Zibari GB, Lipka J, Zizzi H, Abreo KD, Jacobbi L, McDonald JC (2000) The use of contaminated donor Organs in transplantation. Clin Transplant 14(4 Pt 2):397–400
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Steinkopff Verlag
About this chapter
Cite this chapter
Lauchart, W., Wachsmuth, C. (2006). Untersuchungen des Organspenders zum Schutz des Organempfängers vor übertragbaren Erkrankungen. In: Mauer, D., Gabel, D. (eds) Intensivmedizin und Management bei Organspende und Transplantation. Steinkopff. https://doi.org/10.1007/3-7985-1611-1_4
Download citation
DOI: https://doi.org/10.1007/3-7985-1611-1_4
Publisher Name: Steinkopff
Print ISBN: 978-3-7985-1597-0
Online ISBN: 978-3-7985-1611-3
eBook Packages: Medicine (German Language)